Seqens is an integrated global leader in pharmaceutical synthesis and specialty ingredients, delivering outstanding performance, unrivalled market responsiveness and custom-made solutions to our customers. Seqens operates 24 industrial plants and 3 R&D centers in Europe, North America and Asia. More than 300 scientists, engineers and other experts develop tailor-made solutions for our customers and ensure that products are successfully transferred into production. In the pharmaceutical industry, Seqens supports our customers in developing, scaling up and manufacturing drug substances from the pre-clinical phase to the commercial phase. We also offer a large portfolio of APIs and proprietary intermediates.